# CABAZITAXEL
> **ANDA207735** · Abbreviated New Drug Application (Generic) · Sponsor: BPI LABS LLC · Approved 2023-03-22
## Drug
- **FDA Application Number:** ANDA207735
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** CABAZITAXEL
- **Generic name:** Cabazitaxel
- **Active ingredients:** CABAZITAXEL
- **Dosage form:** UNKNOWN
- **Route:** UNKNOWN
- **Marketing status:** None (Tentative Approval)
- **Sponsor:** BPI LABS LLC
- **First approval:** 2023-03-22
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=207735)
---
*MORVS · CC0 1.0*